Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.

Article  PubMed  PubMed Central  Google Scholar 

Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J Surg [Internet]. 2018;42:615–22. Available from: https://doi.org/10.1007/s00268-018-4479-z.

Bongers PJ, Greenberg CA, Hsiao R, Vermeer M, Vriens MR, Lutke Holzik MF, et al. Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. Surgery. 2020;167:94–101.

Article  PubMed  Google Scholar 

Nickel B, Tan T, Cvejic E, Baade P, McLeod DSA, Pandeya N, et al. Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment. JAMA Otolaryngol Head Neck Surg. 2019;145:231.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Qiu Y, Fei Y, Xing Z, Zhu J, Su A. Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis. Endocrine. 2020;70:243–55.

Article  PubMed  Google Scholar 

Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, et al. The impact of the extent of surgery on the long-term outcomes of patients with low-risk differentiated non-medullary thyroid cancer: a systematic meta-analysis. J Clin Med. 2020;9:2316.

Article  PubMed  PubMed Central  Google Scholar 

Chan S, Karamali K, Kolodziejczyk A, Oikonomou G, Watkinson J, Paleri V, et al. Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer. Eur Thyroid J. 2020;9:73–84.

Article  PubMed  PubMed Central  Google Scholar 

Metman MJH, Lončar I, Kruijff S, Engelsman AF, van Ginhoven TM. Is less always more in a national well-differentiated thyroid cancer population? Eur J Surg Oncol. 2020;46((4 Pt A)):709–11.

Article  CAS  PubMed  Google Scholar 

Lu C, Wang Y, Yu M. Is ultrasonographic evaluation sensitive enough to detect multicentric papillary thyroid carcinoma? Gland Surg. 2020;9(3):737–46.

Article  PubMed  PubMed Central  Google Scholar 

Grani G, Cera G, Conzo G, Del Gatto V, Di Gioia CRT, Maranghi M, et al. Preoperative ultrasonography in the evaluation of suspected familial non-medullary thyroid cancer: are we able to predict multifocality and extrathyroidal extension? J Clin Med. 2021;10(22):5277.

Article  PubMed  PubMed Central  Google Scholar 

Moon JH, Kim JH, Lee EK, Lee KE, Kong SH, Kim YK, et al. Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro). Endocrinol Metab. 2018;33:278–86.

Article  Google Scholar 

Jonker PKC, Metman MJH, Sondorp LHJ, Sywak MS, Gill AJ, Jansen L, et al. Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection. Eur J Nucl Med Mol Imaging. 2022;49(10):3557–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol. 1993;121(1):145–54.

Article  CAS  PubMed  Google Scholar 

Ménard L, Parker PJ, Kermorgant S. Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat Commun. 2014;5:3907.

Article  PubMed  Google Scholar 

Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, et al. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. J Pathol. 2007;213(2):190–9.

Article  CAS  PubMed  Google Scholar 

Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O, et al. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab. 1997.

Cheng JY, Brown TC, Murtha TD, Stenman A, Juhlin CC, Larsson C, et al. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis. BMC Cancer. 2017;17(1):164.

Article  PubMed  PubMed Central  Google Scholar 

Koo BS, Kim JM, Seo ST, Yoon YH, Kwon KR, Kim SH, et al. Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol. 2014;21(7):2310–7.

Article  PubMed  Google Scholar 

Zhai T, Muhanhali D, Jia X, Wu Z, Cai Z, Ling Y. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer. Endocrine. 2019;66(3):573–84.

Article  CAS  PubMed  Google Scholar 

Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, et al. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat Commun. 2018;9:1–11.

Article  CAS  Google Scholar 

Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A. 2001;98(26):15044–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fluge Ø, Haugen DRF, Lillehaug JR, Varhaug JE. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue. World J Surg. 2001;25(5):623–31.

Article  CAS  Google Scholar 

Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab. 2004;89(7):3214–23.

Article  CAS  PubMed  Google Scholar 

Ruco LP, Stoppacciaro A, Ballarini F, Prat M, Scarpino S. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol. 2001;194(1):4–8.

Article  CAS  PubMed  Google Scholar 

Oyama T, Ichimura E, Sano T, Kashiwabara K, Fukuda T, Nakajima’ T, et al. c-Met expression of thyroid tissue with special reference to papillary carcinoma. Pathol Int. 1998;48(10):763–8.

Article  CAS  PubMed  Google Scholar 

Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, et al. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid. 1998;8:125–31.

Article  CAS  PubMed  Google Scholar 

Ruco LP, Ranalli T, Marzullo A, Bianco P, Prat M, Comoglio PM, et al. Expression of met protein in thyroid tumours. J Pathol. 1998;48(10):763–8.

Google Scholar 

Zanetti A, Stoppacciaro A, Marzullo A, Ciabatta M, Fazioli F, Prat M, et al. Expression of met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol. 1998;186(3):287–91.

Article  CAS  PubMed  Google Scholar 

Scarpino S, d’Alena FC, Di Napoli A, Pasquini A, Marzullo A, Ruco LP. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-I (HIF-I) in tumour cells in papillary carcinoma of the thyroid. J Pathol. 2004;202(3):352–8.

Article  CAS  PubMed  Google Scholar 

de Jongh SJ, Vrouwe JPM, Voskuil FJ, Schmidt I, Westerhof J, Koornstra JJ, et al. The optimal imaging window for dysplastic colorectal polyp detection using c-Met targeted fluorescence molecular endoscopy. J Nucl Med. 2020;61(10):1435–41.

Article  PubMed  Google Scholar 

Steinkamp PJ, Pranger BK, Li M, Linssen M, Voskuil FJ, Been L, et al. Fluorescence-guided visualization of soft tissue sarcomas by targeting vascular endothelial growth factor-A: a phase 1 single-center clinical trial. J Nucl Med. 2021;62(3):342–7.

Article  CAS  PubMed  Google Scholar 

Voskuil FJ, de Jongh SJ, Hooghiemstra WTR, Linssen MD, Steinkamp PJ, de Visscher SAHJ, et al. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: a quantitative dose-escalation study. Theranostics. 2020;10:3994–4005.

Article  CAS  PubMed